Monthly Communication Report

Corporation:	LEO PHARMA INC.
Associated registration:	940375-12014-3
Communication date:	2018-11-16
Posted date:	2018-11-30

Designated Public Office Holders who participated in the communication:	Benoit Leduc, Manager Innovation, Science and Economic Development Canada (ISED) Footnote1 Kate Proctor, Policy Advisor Treasury Board Of Canada Secretariat (TBS) Kevin Deagle, Policy Advisor Indigenous Services Canada (ISC) Footnote1 Rodrigo Arancibia, Director, Life Sciences Branch Innovation, Science and Economic Development Canada (ISED) Footnote1 Kate Moussouni, Senior Policy Advisor Health Canada (HC) Joseph Wabegijig, Policy Advisor Indigenous Services Canada (ISC) Footnote1
Subject Matter of the communication:	Health
Responsible Officer who filed this communication report:	Kristian Fick
As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication. The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed.
Footnote1  Indicates new information that was added through a monthly communications return.